THE sequence of hemoglobinuria followed by oliguria and anuria is well known. The observations reported below are especially concerned with the medical management of the anuric patient and with the ...

Jan. 6, 2006 -- The US Food and Drug Administration (FDA), Cangene Corporation, and Baxter Healthcare Corporation have warned healthcare professionals via letter regarding the rare risk for serious ...

Is This Intravascular Immune Hemolysis? The term "immune" implies that the hemolysis is antibody-related. Because the type and antibody screen and the DAT were negative, the hemolysis was probably not ...

Background A 43-year-old African-American female (gravida 5 para 0) with an 8-week intrauterine pregnancy presented to the emergency room with crampy abdominal pain, shortness of breath, and shoulder ...

The FDA, Cangene, and Baxter have notified healthcare professionals that cases of intravascular hemolysis (IVH) and its complications have been reported in patients treated for immune thrombocytopenic ...

Division of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Centre, and the Division of Hematopathology, Vancouver General Hospital, Vancouver, BC, Canada Division of Medical ...

Please provide your email address to receive an email when new articles are posted on . Ravulizumab led to maintained control of intravascular hemolysis and sustained stable hemoglobin levels ...

The phase 3 PEGASUS trial found that patients with paroxysmal nocturnal hemoglobinuria (PNH) may still experience anemia following recommended therapies, underscoring the need for further research. In ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and lethal disorder of the blood in which the body attacks and destroys red blood cells in massive amounts. This focus collection and short ...

In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader ...